DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
1-Year Return
0.48%
This Quarter Return
-19.64%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$240M
AUM Growth
-$51.7M
(-18%)
Cap. Flow
+$13.5M
Cap. Flow
% of AUM
5.62%
Top 10 Holdings %
Top 10 Hldgs %
50.22%
Holding
91
New
10
Increased
29
Reduced
12
Closed
11
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$6.13M |
| 2 |
Compugen
CGEN
|
$4.36M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$3.39M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$3.24M |
| 5 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
$2.63M |
Top Sells
| 1 |
ARQL
Arqule Inc
ARQL
|
$9.94M |
| 2 |
Cytokinetics
CYTK
|
$4.44M |
| 3 |
VYNE Therapeutics
VYNE
|
$3.7M |
| 4 |
AtriCure
ATRC
|
$2.65M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$2.65M |
Sector Composition
| 1 | Healthcare | 91.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
26
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.71M | 1.13% |
147,714
+29,400
| +25% | +$540K |
|
|
SIOX
27
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $2.49M | 1.04% |
+1,021,566
| New | +$2.49M |
|
28
Mersana Therapeutics
MRSN
$35.5M
| $2.34M | 0.98% |
16,065
+11,726
| +270% | +$1.71M |
|
|
KDMN
29
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.33M | 0.97% |
556,564
+182,141
| +49% | +$763K |
|
|
BEAT
30
DELISTED
BioTelemetry, Inc.
BEAT
| $2.33M | 0.97% |
60,500
+5,200
| +9% | +$200K |
|
31
Viking Therapeutics
VKTX
$2.98B
| $2.11M | 0.88% |
450,900
+241,700
| +116% | +$1.13M |
|
|
TPTX
32
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.1M | 0.87% |
46,908
+16,500
| +54% | +$737K |
|
|
CSII
33
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.8M | 0.75% |
51,200
+5,000
| +11% | +$176K |
|
34
KalVista Pharmaceuticals
KALV
$765M
| $1.8M | 0.75% |
234,952
+210,227
| +850% | +$1.61M |
|
|
AFMD
35
DELISTED
Affimed
AFMD
| $1.79M | 0.75% |
113,340
-16
| -0% | -$253 |
|
|
HARP
36
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $1.71M | 0.71% |
+14,747
| New | +$1.71M |
|
|
EPZM
37
DELISTED
Epizyme, Inc
EPZM
| $1.64M | 0.69% |
105,900
+37,900
| +56% | +$588K |
|
38
Apellis Pharmaceuticals
APLS
$3.62B
| $1.45M | 0.6% |
54,054
+13,397
| +33% | +$359K |
|
|
AUTL
39
Autolus Therapeutics
AUTL
$386M
| $1.32M | 0.55% |
219,800
+119,800
| +120% | +$718K |
|
40
Accuray
ARAY
$170M
| $1.28M | 0.53% |
674,300
| – | – |
|
41
Johnson & Johnson
JNJ
$431B
| $1.23M | 0.51% |
9,400
| – | – |
|
42
Inogen
INGN
$220M
| $1.19M | 0.5% |
23,000
| – | – |
|
|
BLUE
43
DELISTED
bluebird bio
BLUE
| $1.17M | 0.49% |
1,969
| – | – |
|
44
Zymeworks
ZYME
$1.07B
| $1.14M | 0.47% |
+32,000
| New | +$1.14M |
|
|
PHAS
45
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $1.06M | 0.44% |
320,542
-40,000
| -11% | -$132K |
|
46
Ardelyx
ARDX
$1.58B
| $1.05M | 0.44% |
184,850
-15,000
| -8% | -$85.3K |
|
|
NTUS
47
DELISTED
Natus Medical Inc
NTUS
| $992K | 0.41% |
42,900
| – | – |
|
48
BioCryst Pharmaceuticals
BCRX
$1.74B
| $958K | 0.4% |
479,051
-35,000
| -7% | -$70K |
|
49
Neuronetics
STIM
$219M
| $937K | 0.39% |
495,772
+100,000
| +25% | +$189K |
|
|
GNCA
50
DELISTED
Genocea Biosciences, Inc.
GNCA
| $933K | 0.39% |
542,564
| – | – |
|